Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Operating Income: 2019-2025

Historic Operating Income for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -$7.1 million.

  • Biodesix's Operating Income rose 17.93% to -$7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.6 million, marking a year-over-year increase of 6.23%. This contributed to the annual value of -$34.5 million for FY2024, which is 16.55% up from last year.
  • Per Biodesix's latest filing, its Operating Income stood at -$7.1 million for Q3 2025, which was up 27.45% from -$9.7 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Operating Income registered a high of -$5.6 million during Q1 2021, and its lowest value of -$16.4 million during Q1 2023.
  • Over the past 3 years, Biodesix's median Operating Income value was -$8.6 million (recorded in 2024), while the average stood at -$9.2 million.
  • As far as peak fluctuations go, Biodesix's Operating Income crashed by 340.22% in 2021, and later spiked by 50.54% in 2023.
  • Quarterly analysis of 5 years shows Biodesix's Operating Income stood at -$11.7 million in 2021, then dropped by 18.93% to -$13.9 million in 2022, then skyrocketed by 50.54% to -$6.9 million in 2023, then increased by 3.22% to -$6.6 million in 2024, then grew by 17.93% to -$7.1 million in 2025.
  • Its last three reported values are -$7.1 million in Q3 2025, -$9.7 million for Q2 2025, and -$9.1 million during Q1 2025.